CVE-2015-3459

CVE-2015-3459 is a critical-severity vulnerability in Hospira Lifecare Pcainfusion Firmware with a CVSS 2.0 base score of 10.0. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-264.

Key facts

Description

The communication module on the Hospira LifeCare PCA Infusion System before 7.0 does not require authentication for root TELNET sessions, which allows remote attackers to modify the pump configuration via unspecified commands.

Frequently asked questions

What is CVE-2015-3459?
The communication module on the Hospira LifeCare PCA Infusion System before 7.0 does not require authentication for root TELNET sessions, which allows remote attackers to modify the pump configuration via unspecified commands.
How severe is CVE-2015-3459?
CVE-2015-3459 has a CVSS 2.0 base score of 10.0, rated critical severity.
Is CVE-2015-3459 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 5% (91st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2015-3459?
CVE-2015-3459 primarily affects Hospira Lifecare Pcainfusion Firmware. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2015-3459?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2015-3459 published?
CVE-2015-3459 was published on 2015-04-29 and last updated on 2026-06-17.

References

Affected products (3)

More vulnerabilities in Hospira Lifecare Pcainfusion Firmware

All CVEs affecting Hospira Lifecare Pcainfusion Firmware →

Other CWE-264 (Permissions, Privileges, and Access Controls) vulnerabilities

Browse all CWE-264 (Permissions, Privileges, and Access Controls) vulnerabilities →